VeriChip Corporation Adds 67 Hospitals/Emergency Rooms to Its VeriMed Patient Identification System Network at the Annual American College of Emergency Physicians Conference
Posted on: Thursday, 19 October 2006, 12:00 CDT
VeriChip Corporation, a subsidiary of Applied Digital Solutions (NASDAQ:ADSX), announced today that 67 new healthcare facilities agreed to participate in the VeriMed Patient Identification System Network at the recently completed American College of Emergency Physicians (ACEP) Conference in New Orleans held from October 15-18.
The new healthcare facilities agreed to use the VeriMed reader as standard protocol to scan patients that arrive in emergency rooms unconscious, delirious or confused. The Company continues to provide readers to hospitals and other healthcare facilities at no charge as part of its efforts to "seed" the infrastructure for the VeriMed patient identification system. The new healthcare facilities bring the total number of hospitals and healthcare facilities, located in states that have agreed to adopt the VeriMed System, to 252.
"We continue to gain traction among leading hospitals as a result of our marketing initiatives at many leading medical conferences, as well as the increasing recognition of the role that the VeriMed Patient Identification System can play in critical care situations," stated Kevin McLaughlin, CEO of VeriChip Corporation. "We continue to focus on both leading hospitals and influential physicians as we develop our footprint throughout the country."
The VeriMed System, which consists of a hand-held radio frequency identification (RFID) scanner, an implantable RFID microchip, and a secure patient database, is being used to help rapidly identify and provide access to important health information on participating patients who arrive at the emergency department unconscious, delirious, or unable to communicate.
About VeriChip Corporation
VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. VeriChip sells passive RFID systems for identification purposes and active RFID systems for local-area location and identification purposes. VeriChip recently began to market its VeriMed(TM) Patient Identification System which is used to rapidly and accurately identify people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration. For more information on VeriChip, please call 1-800-970-2447, or email info@verichipcorp.com. Additional information can be found online at www.verichipcorp.com.
About Applied Digital - "The Power of Identification Technology"
Applied Digital develops innovative identification and security products for consumer, commercial, and government sectors worldwide. The Company's unique and often proprietary products provide identification and security systems for people, animals, the food supply, government/military arena, and commercial assets. Included in this diversified product line are RFID applications, end-to-end food safety systems, GPS/Satellite communications, and telecomm and security infrastructure, positioning Applied Digital as the leader in identification technology. Applied Digital is the owner of a majority position in Digital Angel Corporation (AMEX:DOC).
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.
Source: Business Wire
Related Articles
- ATTO Technology Announces Integration of 3-Gb SAS RAID Adapter With the Inscriber(R) G7(TM) Broadcast Graphics System From Harris Corporation
- VeriChip Corporation and Digital Angel Corporation to Disclose Additional Details on Implantable RFID Glucose-Sensing Microchip for Humans on December 4th and 5th in New York
- VeriChip Corporation and Digital Angel Corporation to Accelerate Development of Implantable RFID Glucose-Sensing Microchip for Humans Through Development Agreement With RECEPTORS LLC
- Digital Angel Corporation and Verichip Corporation Form Joint Committee to Design and Develop Implantable Glucose-Sensing Microchip
- Wellmont Health System and HealthSouth Corporation Announce Partnership to Operate Rehabilitation Hospitals in Tennessee and Virginia
- Misys Healthcare Systems and Wellsoft Corporation Create Complete Hospital Technology Solution
- Digital Angel Corporation Awarded Patent for Breakthrough Glucose-Sensing RFID Microchip
- The Walt Disney Company, Cisco Systems and Intel Corporation Invest in MovieBeam, Inc.
- Texas Instruments Names Julie England General Manager of RFID Systems Group
- Intellident Joins Texas Instruments RFid Systems Worldwide Team Tag-it(TM) Program
User Comments (0)

RSS Feeds